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Abstract
Background: Leptin (Lep) is known for its involvement in the regulation of reproductive functions. It is important
for uterine receptivity, implantation, placental growth and maternal energy homeostasis in several species, but Lep’s
function in the pregnant dog has not been investigated.
Methods: Pregnant bitches were ovariohysterectomized at pre-implantation, post-implantation, mid-gestation and
prepartum luteolysis. Two additional groups were treated with aglepristone in mid-gestation, and ovariohysterectomized
24 or 72 h later. Lep and leptin receptor (LepR) gene expression was detected by semi-quantitative real-time
PCR in pre-implantation and inter-placental uterine sections (Ut) and in utero-placental compartments (Ut/Pl).
Immunohistochemistry and in situ hybridization (ISH) were performed for Lep and LepR protein and mRNA localization.
Parametric one-way ANOVA, paired t-test and Wilcoxon signed-rank test were used for statistical analysis.
Results: In the Ut/Pl, Lep expression was higher at post-implantation and prepartum luteolysis than at mid-gestation,
while in the Ut, Lep mRNA levels did not change during pregnancy. LepR expression in the Ut/Pl was up-regulated
at prepartum luteolysis compared to the earlier stages. In the Ut, highest LepR mRNA was found at pre- and
post-implantation. LepR expression was down-regulated in the Ut/Pl compared to the Ut at post-implantation
and at mid-gestation. Aglepristone treatment resulted in a decrease of Lep mRNA levels from 24 to 72 h in
the Ut without concomitant changes in the Ut/Pl or in LepR levels. Lep and LepR immunoreactivities were
strong in the luminal and glandular epithelium in the Ut with abundant LepR signals in the subepithelial
stroma. In the Ut/Pl, fetal trophoblasts stained stronger for Lep and LepR than decidual cells, and signals for
both proteins were also detected in the glandular chambers. The myometrium, blood vessel media, and sporadically
also the endothelium stained for Lep and LepR. ISH showed similar signal distribution in the Ut and Ut/Pl.
Conclusions: Lep and LepR are differentially expressed in the canine uterus and placenta during pregnancy, and
their presence in various cell types indicates paracrine/autocrine roles. The Lep signaling system may be one
of the pathways involved in feto-maternal cross-talk, implantation and maintenance of pregnancy, and may
have a regulatory role around parturition.
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Background
Leptin (Lep) was originally thought to be secreted exclu-
sively by adipose tissue, regulating energy metabolism and
satiety [1]. Soon thereafter it became clear that Lep affects
reproductive processes both centrally and peripherally,
and its local expression within reproductive tissues also
supports paracrine/autocrine actions through its receptors
[2-7]. During gestation, Lep concentrations in maternal
serum are significantly increased in, e.g., women, rats,
mice and mares [8-12] and decrease after birth, indicat-
ing a physiological role in pregnancy. Besides adipose
tissue, human, rat and murine placentae also express Lep
[10,13,14], but it seems that the placental contribution to
circulating levels is only functionally significant in women
[7]. Lep regulates various processes that are crucial for
placental development and function including nutrient
transfer across and within the placenta [15,16]. Addition-
ally, Lep has also angiogenic properties [17,18].
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Fetal trophoblast cells invade the maternal endomet-
rium in species with invasive placentation like humans,
rodents, and to some extent also in dogs [19]. Lep pro-
motes trophoblast invasion in humans by acting on
matrix metalloproteinase 2 (MMP-2) and MMP-9, which
are regarded as key enzymes for successful implantation
[20,21]. In vitro, Lep stimulated MMP-2 secretion and
the activity of MMP-2 and MMP-9 from human cytotro-
phoblasts [22,23] as well as invasion by day 10 murine
trophoblast cells [24]. Furthermore, already in early
pregnancy, both at the pre-implantation phase and dur-
ing the window of implantation, Lep was shown to regu-
late uterine receptivity and embryo development in
species other than the dog [25-30]. Human endometrial
epithelial cells treated with Lep in vitro expressed higher
levels of β3 integrin, leukemia inhibitory factor (LIF),
interleukin-1 (IL-1) and their receptors [25,26], which fa-
cilitate embryo adhesion and have immuno-modulatory
roles during embryo-maternal interaction. It seems that
the developing pre-implantation embryo is under the local
influence of maternal Lep in the uterus and can respond
to it, as LepR expression was found in oocytes and em-
bryos from the 2-cell to 8-cell or blastocyst stages [27-29].
Lep increased cell numbers and blastocyst formation rates
in murine and ovine embryos [27,28], but reduced quality
and developmental rate in horses [29].
In dogs, maintenance of pregnancy is dependent on an
adequate supply of progesterone (P4), the sole source of
which is the corpus luteum (CL), as the placenta is de-
void of steroidogenic activity [31-33]. The luteal phase
in pregnant and non-pregnant dogs is comparable in
length and in peripheral levels of P4, estrogens and pro-
lactin (PRL), and only relaxin concentrations are different
since it is produced by the placenta [32,34-36]. Therefore,
other endocrine and molecular mechanisms may already
be crucial early on to support survival of the embryo and
to maintain a successful pregnancy. During early canine
embryo-maternal contact, differential gene expression
of members of the prostaglandin synthesis pathway, growth
factors, cytokines, immune cell receptors, steroid hormone
receptors and the PRL receptor points to the role of
the blastocyst to interact with the uterine milieu to signal
its presence [37-40]. Some of the above-mentioned factors
are also expressed at the time of implantation-placentation,
as shown by Beceriklisoy et al. [39], Kowalewski et al.
[41,42] and Gram et al. [43].
Lep’s role in canine reproduction and especially during
pregnancy is not extensively studied and is poorly under-
stood, although the positive relationship with short- and
long-term energy status and obesity is well known [44-46].
Lep is produced in proportion to the amount of fat de-
pots, and its peripheral concentration correlates with adi-
posity regardless of gender, breed, age and neuter status
[46]. However, Saleri et al. [47] measured higher levels of
Lep in female than in male dogs, which also varied accord-
ing to the stage of the reproductive cycle. Up-regulation of
Lep gene expression in the CL during the early luteal
phase in non-pregnant bitches [48], and the presence of
Lep immunoreactive protein in luteal cells and in granu-
losa cells of mature luteinized follicles [49], may indicate a
positive action of Lep on follicular and luteal function
and perhaps on steroid hormone production in the
dog. To date, Lep expression in the canine uterus was only
examined in the first half of gestation using qualitative
PCR, which yielded negative results [37,39]. Bartel et al.
[50] found Lep and LepR immunoreactivity in the uteri of
non-pregnant bitches, but pregnant dogs were not studied.
The role of Lep in canine uterine and placental func-
tion during gestation is still not clear and has not been
investigated in detail. We hypothesize that the canine
placenta is a source of Lep, and that Lep signaling may
be involved in the regulation of pregnancy establishment
and maintenance. Therefore, in this study, we deter-
mined relative gene expression of Lep and LepR in full-
thickness uterine (Ut) and utero-placental (Ut/Pl) sections
of bitches from various stages of pregnancy and after
aglepristone-induced abortion in mid-gestation; the latter
experiment was to compare to changes occurring during
parturition. Additionally, Lep and LepR protein and
mRNA were localized by immunohistochemistry (IHC)
and in situ hybridization (ISH), respectively, in representa-
tive sections of the Ut and Ut/Pl during gestation.
Methods
All uterine and utero/placental tissues used in this study
were collected in the framework of previous studies [41,51],
in accordance with the appropriate animal welfare legisla-
tions. Animal experiments were approved by the respective
ethics committees and conducted under permit no. II 25.3-
19c20-15c GI 18/14 and VIG3-19c20/15c GI 18,14 (Justus-
Liebig University, Giessen), and permit no. Ankara 2006/
06 (Faculty of Veterinary Medicine, University of Ankara).
Animals
Healthy bitches (2–8 years, different breeds) were mated
2 days after ovulation (serum P4 ≥ 5 ng/mL) [52]. Day of
mating was designated as day 0. Dogs were ovariohyster-
ectomized on d 8–12 (pre-implantation, n = 5), d 18–25
(post-implantation; n = 5), d 35–40 (mid-gestation; n = 5)
and during prepartum luteolysis (n = 3; defined as P4 <
3 ng/ml in two consecutive serum samples taken 6 h apart
starting from d 58). Additionally, bitches on d 40–45 of
gestation were treated with the progesterone-receptor
blocker aglepristone (Alizin®, Virbac, Carros Cedex, France;
10 mg/kg BW subcutaneously twice, 24 h apart) to induce
abortion, and were ovariohysterectomized 24 or 72 h after
the last injection (n = 4 per group). At the pre-implantation
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stage, pregnancy was confirmed by detecting embryos in
uterine flushes immediately after surgery.
Tissue samples
Full thickness Ut samples were collected from bitches in
the pre-implantation group. From the post-implantation
stage until prepartum luteolysis, full thickness Ut/Pl and
inter-placental Ut sections were collected. Inter-placental
Ut was not available from the prepartum luteolysis group.
For preservation of RNA, all tissues were incubated over-
night in RNAlater® at 4°C (Ambion Biotechnologie GmbH,
Wiesbaden) and afterwards stored at −80°C. For IHC and
ISH, all tissues were fixed in 10% neutral phosphate-
buffered formalin at 4°C for 24 h, washed daily in phos-
phate buffered saline for one week, dehydrated in a graded
ethanol series and embedded in paraffin-equivalent Histo-
Comp (Vogel, Giessen, Germany) or paraffin [41,53].
Semi-quantitative real-time (TaqMan) PCR
After isolation of total RNA using TRIzol® Reagent (Invitrogen,
Carlsbad, CA, USA), 100–200 ng of RNA per sample
was DNAse treated (RQ1 RNase-free DNase; Promega,
Dübendorf, Switzerland) to eliminate genomic DNA con-
tamination according to the manufacturer’s instructions
and as previously described [54]. Reverse transcription
was carried out in an Eppendorf Mastercycler Thermal
Cycler (Vaudaux-Eppendorf AG, Basel, Switzerland) using
reagents from Applied Biosystems (Foster City, CA, USA)
according to our protocols [54]. Semi-quantitative real-time
(TaqMan) PCR for the detection of canine Lep [GenBank:
NM_001003070] and LepR [GenBank: NM_001024634;
only the long isoform is known] was carried out using the
same primers and TaqMan probes as previously reported
by our group [48], i.e.,: Lep (forward): 5’-GGG TCG CTG
GTC TGG ACT T-3’, Lep (reverse): 5’-CTG TTG GTA
GAT GGC CAA CGT-3’, Lep TaqMan probe: 5’-TCC
TGG GCT CCA ACC AGT CCT GAG T-3’; LepR
(forward): 5’-CAT TTG CGG AGG GAT GGT T-3’, LepR
(reverse): 5’-AGC GGT TTC ACC ACG GAA T-3’,
LepR TaqMan probe: 5’-TTG ACT CTT CAC CAA CGT
GTG TGG TTC C-3’. TaqMan probes were labeled at the
5’-end with the reporter dye 6-carboxyfluorescein (FAM),
and at the 3’-end with the quencher 6-carboxytetramethyl-
rhodamine (TAMRA). Reactions were carried out in
an automated fluorometer (ABI PRISMTM 7500 Sequence
Detection System, Applied Biosystems, Darmstadt,
Germany) using 96-well optical plates following our pro-
tocols [55,56]. Samples were run in duplicates. Canine
GAPDH [GenBank: AB028142] (GAPDH (forward): 5’-
GCT GCC AAA TAT GAC GAC ATC A-3’, GAPDH (re-
verse): 5’-GTA GCC CAG GAT GCC TTT GAG-3’,
GAPDH TaqMan probe: 5’-TCC CTC CGA TGC CTG
CTT CAC TAC CTT-3’) [54] and cyclophyllin A (Prod.
No. Cf03986523-gH, Applied Biosystems, Foster City,
CA, USA) served as reference genes, and autoclaved water
instead of cDNA was used as negative control.
Immunohistochemistry
An indirect immunoperoxidase method was used on tis-
sue samples collected from pregnant dogs according to
Kowalewski et al. [54]. For the detection of Lep, a rabbit
polyclonal affinity purified antibody directed against
the N-terminal region of the human leptin (ARP41697_P050,
Aviva Systems Biology, San Diego, USA) diluted 1:200 was
used, and for LepR, a goat polyclonal affinity purified anti-
body raised against a peptide mapping at the C-terminus
of the short form of LepR of mouse origin and recom-
mended for the detection of both short and long LepR iso-
forms (Ob-R (M-18): sc-1834, Santa Cruz Biotechnology
Inc., CA, USA) diluted 1:50. Briefly, 2–3 μm thick sections
of Ut/Pl and uterine tissues were mounted on SuperFrost
Plus microscope slides (Menzel-Gläser, Braunschweig,
Germany), deparaffinized in xylol and rehydrated in a
graded ethanol series. Antigen retrieval was achieved by
heat induction, incubating slides in 10 mM citrate buffer
(pH 6.0) for 15 min at 100°C. Endogenous peroxidase
activity was quenched with 0.3% hydrogen peroxide in
methanol. Non-specific binding sites were blocked with
10% goat serum (for Lep; KPL, Gaithersburg, USA)
or 10% horse serum (for LepR; Vector Laboratories,
Burlingame, USA). Slides were incubated with the pri-
mary antibodies overnight at 4°C. Biotinylated goat anti-
rabbit IgG and horse anti-goat IgG (Vector Laboratories,
Burlingame, USA) at a dilution of 1:100 were used as
secondary antibodies for Lep and LepR, respectively.
Signals were enhanced using the avidin/biotinylated per-
oxidase complex (Vectastain ABC Kit, Vector Laboratories,
Burlingame, USA) and color reactions were achieved by
applying 3,3’-diaminobenzidine (DAB) as chromogen sub-
strate (Liquid DAB+ substrate Kit, Dako Schweiz AG,
Baar, Switzerland). Finally, slides were counterstained with
Mayer’s hematoxylin, dehydrated in a graded ethanol
series and covered with coverslips. Isotype controls were
carried out with pre-immune rabbit (for Lep) and goat
(for LepR) IgG (Vector Laboratories, Burlingame, USA).
Murine ovaries with corpora lutea were used as positive
controls for both Lep and LepR.
In situ hybridization (ISH)
A non-radioactive method [55] was used for tissue
localization of Lep and LepR mRNA in representative
samples of Ut and Ut/Pl. Templates for cRNA probe syn-
thesis were generated by the following canine-specific
primers: Lep (forward) - 5’-ATG CGT TGT GGA CCT
CTG TG-3’, Lep (reverse) - 5’-GGT TGG AGC CCA
GGA ATG AA-3’, amplicon length 203 bp; LepR (for-
ward) - 5’-CAT GGT GGG TGA CCG TGT TA-3’, LepR
(reverse) - 5’-TCC CTC GAG TGA TTG GAT TGC-3’,
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amplicon length 232 bp. PCR products were separated on
a 2% ethidium bromide-stained agarose gel, purified with
the Qiaex II gel extraction system (Qiagen GmbH, Hilden,
Germany) and cloned into a pGEM-T plasmid (Promega,
Dübendorf, Switzerland). The plasmid clones containing
the inserts were digested with restriction enzymes NcoI
and NotI (New England Biolabs, Frankfurt, Germany) to
obtain antisense and sense cRNA probes, respectively,
which were labelled with digoxigenin (DIG-RNA labelling
kit, Roche Diagnostics AG, Rotkreuz, Switzerland). Dot-
blot analysis was carried out with serially diluted DIG-
labeled cRNA on a positively charged nylon membrane
(Roche Diagnostics) for semi-quantitation of labeled
cRNA concentration. Paraffin-embedded cross sections of
Ut and Ut/Pl were dewaxed, rehydrated, digested with
70 μg/ml proteinase K (Sigma-Aldrich Chemie GmbH)
and post-fixed with 4% paraformaldehyde. Hybridization
was carried out overnight at 37°C in a formamide chamber.
Signals for Lep and LepR mRNA were detected by DIG-
labelled cRNA probes and alkaline phosphate-conjugated
sheep anti-DIG Fab fragments (Roche Diagnostics AG,
Rotkreuz, Switzerland) diluted 1:5000 in 1% ovine serum.
Color visualization was performed with 5-bromo-4-
chloro-3-indolyl phosphate in the presence of nitroblue
tetrazolium (NBT/BCIP; Roche Diagnostics AG, Rotkreuz,
Switzerland).
Statistical analysis
Only valid data on Lep and LepR gene expression were
considered, where the relative amount of reference genes
for a sample were constant (i.e., similar in the duplicate
samples). Relative gene expression (RGE) was calculated
by the ΔΔCt method as described [54,56]. Logarithmic
transformation was performed when observed data were
not normally distributed (Kolmogorov-Smirnov test, P <
0.05). A parametric one-way ANOVA followed by Tukey
Honestly Significant Difference was used to compare RGE
of Lep and LepR among pregnancy stages and after aglepris-
tone treatment. We performed paired t-test or Wilcoxon
signed-rank test for the comparison of Lep or LepR mRNA
expression between the Ut/Pl and the Ut in the post-
implantation and mid-gestation stages. Results are presented
A
B
Figure 1 Leptin gene expression in the utero-placental and
uterine compartments during pregnancy. Leptin gene expression
during pregnancy in the utero-placental compartments (A), and in
the pre-implantation uterus and inter-placental uterine sections (B).
RGE: relative gene expression. Bars and whiskers present the geometric
mean and the deviation factor. Bars with different superscripts differ
at P ≤ 0.043.
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Figure 2 Comparison of leptin and leptin receptor gene
expression between utero-placental and inter-placental uterine
sections. Relative gene expression of leptin (A) and leptin receptor
(B) between utero-placental and inter-placental uterine sections at
post-implantation and at mid-gestation. RGE: relative gene expression.
Bars and whiskers present the geometric mean and the deviation
factor, or the mean and standard deviation of observed data in
case of mid-gestation leptin receptor gene expression. Bars with
different superscripts within the same pregnancy stage differ at
P = 0.003 (post-implantation) and P = 0.043 (mid-gestation).
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as mean ± standard deviation of observed data or geomet-
ric mean ± deviation factor in the case of ln-transformed
data. Level of significance was set at P ≤ 0.05; statistical
calculations were carried out with IBM® SPSS® Statistics
for Windows, Version 19.0 (Armonk, NY, USA).
Results
Lep in the Ut/Pl and Ut
Lep gene expression during pregnancy and after
aglepristone induced abortion
In the Ut/Pl, we found lower Lep mRNA concentrations
at mid-gestation than at post-implantation and prepartum
luteolysis (P ≤ 0.043; Figure 1A). In the Ut, Lep expression
did not change throughout gestation (P = 0.12; Figure 1B).
Lep mRNA levels were similar between the Ut/Pl and Ut
both at the post-implantation (P = 0.87) and mid-gestation
stages (P = 1.00; Figure 2A).
Induction of abortion with aglepristone in mid-gestation
did not affect Lep gene expression in the Ut/Pl (P = 0.54),
but lower levels were detected in the Ut at 72 h than at 24 h
after the second aglepristone injection (P = 0.05; Figure 3A).
Immunohistochemical detection of Lep during
pregnancy
In the Ut, Lep immunoreactivity was detected in the surface
epithelium and superficial endometrial glands (Figure 4A).
Weaker positive signals were present in the epithelium
of deep uterine glands at pre- and post-implantation,
but at mid-gestation, they became stronger in the deep
glands but were variably present in the endometrial
stroma (Figure 4C).
In the Ut/Pl, fetal trophoblasts of the placental labyrinth
stained positively for Lep, and maternal decidual cells
had weaker signals at all pregnancy stages (Figure 5A,C).
Invading trophoblast cells surrounding large maternal ves-
sels at the base of the placental labyrinth showed intense
immunoreactivity (Figure 5C inset). Epithelial cells of the
glandular chambers stained weakly with signals present
also in the stroma (Figure 5E).
Lep was also detected in smooth muscle cells of the
myometrium (Figures 4A upper right inset and 5E inset)
and of blood vessels, and sporadically in the endothe-
lium (Figures 4A,C and 5A,C).
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Figure 3 Leptin and leptin receptor gene expression in the utero-placental and uterine compartments after abortion induced with
aglepristone. Leptin gene expression (A) in utero-placental compartments and inter-placental uterine sections at mid-gestation, 24 and 72 h
after aglepristone administration. Leptin receptor gene expression (B) in the utero-placental compartments and inter-placental uterine sections at
mid-gestation, 24 and 72 h after aglepristone administration. RGE: relative gene expression. Bars and whiskers present the geometric mean and
the deviation factor or the mean and standard deviation of observed data in case of inter-placental leptin receptor gene expression. Bars with
different superscripts differ at P = 0.05.
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In situ hybridization for Lep
In the Ut, Lep mRNA was found in the luminal and glan-
dular epithelial cells of the endometrium (Figure 6A). In
the Ut/Pl, fetal trophoblasts within the placental labyrinth
gave stronger signals than decidual cells (Figure 6C), while
the epithelium of the glandular chambers and deep uter-
ine glands stained weakly (not shown). Strong positive
signals were also detected in the myometrium (Figure 6A
upper right inset and 6C upper right inset), and occasion-
ally in blood vessel endothelium (Figure 6C).
LepR in the Ut/Pl and Ut
LepR gene expression during pregnancy and after
aglepristone induced abortion
LepR expression in the Ut/Pl increased at the time of
prepartum luteolysis compared to the post-implantation
and mid-gestation stages (P < 0.001; Figure 7A). In the Ut,
LepR mRNA concentrations were higher at pre- and post-
implantation than at mid-gestation (P ≤ 0.019; Figure 7B).
LepR expression was significantly down-regulated in the
Ut/Pl compared to the Ut at post-implantation (P = 0.003)
and at mid-gestation (P = 0.043; Figure 2B).
After aglepristone treatment, LepR mRNA levels in the
Ut/Pl and Ut (Figure 3B) were similar at all time-points
compared to the mid-gestation stage (P = 0.06 and P =
0.63, respectively).
Immunohistochemical detection of LepR during
pregnancy
Strong positive staining for LepR was visible in the uterine
surface epithelium, and the superficial and deep uterine
glands also showed positive reaction. Stromal signals were
Figure 4 Immunohistochemical detection of leptin and leptin receptor in the pre-implantation uterus and inter-placental sections during
pregnancy. Immunohistochemical localization of leptin (Lep; A, C) and leptin receptor (LepR; B, D) in pre-implantation and inter-placental uterine
sections (Ut) during pregnancy. (A) Lep immunostaining at pre-implantation is present in the luminal epithelium (solid arrows) and in the
superficial glands (open arrows); endothelial cells stain occasionally (thin arrow). The myometrium and deep uterine glands also show
positive reaction for Lep (inset upper right); inset (lower left) indicates the isotype control for Lep. (B) LepR immunoreactivity in the Ut at
pre-implantation is noted in the surface epithelium (solid arrows), and in the endometrial stroma close to the lumen (solid arrowheads).
Superficial glands (open arrows) stain weakly, and the myometrium and deep uterine glands also show positive signals (inset upper right);
inset (lower left) shows the isotype control for LepR. (C) Strong Lep staining is visible in the deep uterine glands at mid-gestation; stromal
signals are also evident (solid arrowheads), while endothelial cells show sporadic, weak signals (thin arrows). (D) At mid-gestation, the epithelium of
deep uterine glands has stronger LepR immunoreactivity than at pre-implantation. Stromal signals are still present (solid arrowheads), and signals are
also found occasionally in the endothelium (thin arrows). DG: deep uterine glands, MY: myometrium.
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Figure 5 Immunohistochemical detection of leptin and leptin receptor in the utero-placental compartments during pregnancy.
Immunohistochemical localization of leptin (Lep; A, C, E) and leptin receptor (LepR; B, D, F) in the utero-placental compartments (Ut/Pl) during
pregnancy. (A) Lep signals are strong in fetal trophoblast cells (open arrowheads) of the placental labyrinth at mid-gestation, while maternal
decidual cells (solid arrowheads) stain more weakly and blood vessel endothelial cells (thin arrows) show sporadic signals. (B) LepR positive
trophoblasts (open arrowheads) are present in the placental labyrinth at mid-gestation. LepR immunoreactivity is less intense in decidual cells
(solid arrowheads) and in blood vessel endothelium (thin arrows). (C) Strong Lep immunoreactivity is evident in fetal trophoblast cells (open
arrowheads) of the placental labyrinth at prepartum luteolysis with weaker signals in decidual cells (solid arrowheads) and occasional staining in
the endothelium (thin arrows). Intense signals are detected in trophoblasts at the base of the labyrinth invading large maternal vessels (inset).
(D) LepR positive trophoblast cells (open arrowheads) are shown in the placental labyrinth at prepartum luteolysis with less intense staining in
maternal decidual cells (solid arrowheads) and blood vessel endothelium (thin arrows). The inset shows positive reaction in fetal trophoblast cells
invading large maternal vessels at the base of the labyrinth. (E) Lep staining is present in the epithelial cells of the glandular chambers (solid
arrows) and sporadic signals are also visible in the stroma (solid arrowheads). Positive staining in the myometrium is shown in the inset. (F) In
the glandular chambers, epithelial cells stain positive for LepR (solid arrows) and stromal signals (solid arrowheads) are also present. Positive
immunoreactivity in the myometrium is presented in the inset. MV: maternal vessel, MY: myometrium.
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evident in the endometrium close to the lumen, especially
in the pre-implantation group (Figure 4B). In later preg-
nancy stages, the glandular epithelium stained relatively
more intensely than at pre-implantation (Figure 4D).
In the Ut/Pl, LepR signals were evident in fetal tropho-
blast cells of the placental labyrinth, while maternal de-
cidual cells stained more weakly at all pregnancy stages
(Figure 5B,D). LepR immunoreactivity was especially
strong in the trophoblasts invading large maternal ves-
sels at the base of the labyrinth (Figure 5D, inset). In the
glandular chambers, LepR protein was detected in the
epithelial cells as well as in the stroma (Figure 5F). Deep
uterine glands of the Ut/Pl also showed positive signals
(not shown).
The myometrium (Figures 4B upper right inset and 5F
inset), blood vessel media, and sporadically also blood
vessel endothelial cells (Figures 4D and 5B,D), all stained
positive for LepR in the Ut and Ut/Pl.
In situ hybridization for LepR
In the post-implantation Ut, LepR mRNA was present in
the surface and glandular epithelial cells with strong sig-
nals in the endometrial stroma close to the luminal epi-
thelium (Figure 6B).
In the Ut/Pl at prepartum luteolysis, strong LepR mRNA
expression was detected in the fetal trophoblasts of the
placental labyrinth (Figure 6D), while decidual cells
(Figure 6D) and epithelial cells of the glandular chambers
Figure 6 In situ hybridization for leptin and leptin receptor in the inter-placental uterus and utero-placental compartments during
pregnancy. Localization of leptin (Lep) and leptin receptor (LepR) mRNA by in situ hybridization in inter-placental sections (Ut) at
post-implantation (A, B), and in the utero-placental compartments (Ut/Pl) at prepartum luteolysis (C, D). (A) Lep mRNA expression is evident
in the surface epithelium (solid arrows) and superficial glandular epithelium (open arrows) with weak sub-epithelial stromal signals (solid
arrowheads). Deep uterine glands and the myometrium also stain positively for Lep (inset upper right). A negative control is shown in
the lower left inset. (B) LepR mRNA is expressed in the luminal epithelium (solid arrows) and superficial glandular epithelial cells (open arrows).
Note the prominent stromal signals (solid arrowheads) close to the lumen. The upper right inset is positive staining for LepR in the deep uterine
glands and myometrium, and the lower left inset shows a negative control. (C) Intense Lep expression is noted in the fetal trophoblast
cells (open arrowheads) of the placental labyrinth at prepartum luteolysis, in contrast to weak staining in maternal decidual cells (solid arrowheads)
and sporadic signals in blood vessel endothelium (thin arrows); the upper right inset shows positive reaction in the myometrium, and the lower
left inset is the negative control sense probe for Lep. (D) LepR mRNA expression is strong in the placental labyrinth at prepartum luteolysis
within fetal trophoblast cells (open arrowheads), while decidual cells have less intense signals (solid arrowheads) and endothelial cells (thin arrows)
stain occasionally; the upper right inset shows LepR mRNA in the myometrium, and the lower left inset presents the negative control sense probe for
LepR. DG: Deep uterine glands, MY: Myometrium, MV: maternal vessel.
Balogh et al. Reproductive Biology and Endocrinology  (2015) 13:13 Page 8 of 12
and deep uterine glands showed weaker reactivity. Positive
signals were also present in the myometrium (Figure 6B
upper right inset and Figure 6D upper right inset), and
sporadically in blood vessel endothelial cells (Figure 6D).
Discussion
We found that in the Ut, LepR expression was up-regulated
at pre- and post-implantation compared to mid-gestation
but Lep expression did not change. Additionally, LepR
and Lep were co-localized in the glandular epithelium and
in the luminal epithelial cells of the Ut, which is in direct
contact with the early canine embryo. In the studies of
Kitawaki et al. [57] and Cervero et al. [5], LepR expression
in the human endometrium increased gradually from the
proliferative to the early or mid-late secretory phase coin-
ciding with the time of uterine receptivity and implant-
ation. Protein signals for LepR and Lep in the uteri of
women were predominantly localized in the luminal epi-
thelium, in the endometrial glands and in stromal cells
[3], which is in accordance with our study. Bartel et al.
[50] also described immunoreactivity for both proteins in
the surface and glandular epithelium, and occasional Lep
staining in the stromal parts of the endometrium during
diestrus and anestrus in non-pregnant dogs, but the date
of ovulation was not known. In contrast to our study,
Schäfer-Somi et al. [37] and Beceriklisoy et al. [39] did
not detect Lep mRNA expression by qualitative PCR in
the uterus of non-pregnant bitches in early diestrus or
in pregnant dogs at pre-implantation and at d 20–35
of gestation. In the same study [37], Lep mRNA was not
found in pre-implantation canine embryos either, while
Lep protein and LepR protein and mRNA expression were
not evaluated. The discrepancy between these reports
and ours regarding uterine and utero-placental Lep
expression may be due to methodology, because the semi-
quantitative real-time (TaqMan) PCR used here is more
sensitive than the qualitative approach. The expression/
secretion of downstream molecular markers of endomet-
rial receptivity, e.g., adhesion molecules (β3 integrin) and
cytokines (LIF, IL-1 and their receptors), was also in-
creased after treatment of human endometrial epithelial
cells with Lep [25,26]. In bitches, the expression of integ-
rins is higher in the uterus of early pregnant than repro-
ductive stage-matched non-pregnant diestrous animals
[58]. Our findings therefore suggest that the Lep signaling
pathway may be involved in the early embryo-maternal
cross-talk in the dog.
A role for LepR in the canine implantation/placentation
process may be hypothesized after our study found de-
creased LepR mRNA levels at placentation sites compared
to the inter-placental uterus. In mice, LepR down-regulation
at implantation sites was previously shown by global gene
expression analysis [59], and Yoon et al. [60] also detected
increased LepR expression at inter-implantation compared
to implantation sites in mouse uteri. This hypothesis is
further supported by the results of a recent study [61] in
which women with recurrent implantation failure had
lower endometrial Lep and higher LepR expression com-
pared to fertile controls. These data indicate that, as in
other species, decreased LepR expression at the placenta-
tion site may also be crucial for successful implantation
and placentation in bitches.
Increased Lep expression in the Ut/Pl at post-implantation
compared to mid-gestation may further point to a possible
role for Lep during implantation and placenta formation
in the dog. The localization of Lep and LepR protein and
mRNA in fetal trophoblast cells in our study is in agree-
ment with previous data on women, mice, pigs and cats
[22,62-67], and may imply an autocrine/paracrine effect.
The positive role of Lep was evidenced previously in hu-
man and murine models in vitro, where Lep promoted
fetal trophoblast cell invasion via MMP-2 and −9, and
Lep also showed its mitogenic potential [22-24,68,69].
Taken together, a regulatory, perhaps stimulatory role for
Lep on trophoblast cell migration and proliferation during
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Figure 7 Leptin receptor gene expression in the utero-placental
and uterine compartments during pregnancy. Leptin receptor
gene expression during pregnancy in the utero-placental compartments
(Ut/Pl) (A), and in the pre-implantation uterus and inter-placental
uterine sections (Ut) (B). RGE: relative gene expression. Bars and
whiskers present the geometric mean and the deviation factor.
Bars with different superscripts differ at P < 0.001 (Ut/Pl) and at
P ≤ 0.019 (Ut).
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the process of canine implantation and placentation may
be likely however this cannot be definitely concluded from
our data.
Even though the reason for the prepartum up-regulation
of utero-placental Lep and LepR is still not clear, it could
imply a physiological role in canine parturition. Lep is a
pro-inflammatory cytokine showing structural similarities
to the type I cytokine superfamily [70] and may have an
immune-modulatory function before and during labor. In
women, serum Lep levels were positively correlated with
other cytokines, e.g., IL-6, interferon-ɤ-inducible protein
and C-reactive protein in late pregnancy [71]. During in-
duced parturition, plasma Lep concentrations increased
and were higher in women after spontaneous delivery
than after Cesarean section without labor. Similarly,
Lep expression in the placenta after natural birth was also
higher than after Cesarean section [72]. A stimulatory ef-
fect of Lep on pro-inflammatory mediators was shown by
Lappas et al. [73], where prostaglandin F2α (PGF2α), pros-
taglandin E2, IL-1β, IL-6 and TNFα release was increased
after in vitro treatment of term human placentas with
Lep. In dogs, the source of the PGF2α rise before birth
seems to be the placenta, where enzymes of prostaglandin
biosynthesis (cyclooxygenase 2, prostaglandin E synthase)
are up-regulated prepartum [41]. In our study, the sig-
nificant increase in Lep and LepR expression in the Ut/Pl
at prepartum luteolysis and their localization within
those cells, where members of the prostaglandin synthesis
pathway were also found [41], may suggest an autocrine/
paracrine regulatory role for Lep in the events leading to
parturition in the bitch.
The glandular epithelium was also a site of Lep and
LepR expression both in the Ut and Ut/Pl. An autocrine/
paracrine function regulating endometrial secretory cap-
acity and thus histiotrophe production may be likely.
In pigs, myometrial expression of Lep and LepR tran-
script and protein were detected both in the luteal phase
of the cycle and during pregnancy [65,66]. We also found
Lep and LepR in the muscle layer of the canine uterus
during all pregnancy stages, and therefore it seems that
they are normal constituents of the myometrium. Because
in our experiments full thickness Ut and Ut/Pl tissues
were used, the degree of independent contribution of
the myometrium, endometrium or placental labyrinth
to the detected changes in Lep and LepR gene ex-
pression levels cannot be ascertained without further
compartmentalization studies. Certain tissue layers may
have contributed differently at given time points over the
course of gestation, according to their specific role in the
endocrine and physiological events, e.g., during implant-
ation or parturition. Furthermore, an increasing mass of
the placental labyrinth with advancing pregnancy could
have altered, at least to some extent, the ratio of the uter-
ine compartments at placentation sites.
The LepR antibody used here identifies both the long
and short isoforms of the receptor, which differ in their
ability of signal transduction. While all transmembrane
receptor isoforms can activate the tyrosine kinase Janus
kinase (JAK2), only the long isoform with a full-length
intracellular domain has signal transducer and activator
of transcription (STAT)-binding sites and is able to acti-
vate the main signalling cascade JAK2/ STAT3. However,
the short isoforms are also capable of signalling through
various intracellular pathways and mediate Lep’s actions
(reviewed by [74,75]). Therefore, the long and short
LepR isoforms are relevant to investigate even though
the long isoform is of particular interest, and studies on
the expression/function of the different LepR splice vari-
ants in the dog could be planned.
In a few animals in our study, Lep and/or LepR mRNA
expression was not detected in the Ut or Ut/Pl, which
might have been due to degradation of RNA, sensitivity
of our assay, individual differences in expression levels
or pregnancy stage.
Conclusions
The canine uterus and placenta are sources of Lep and
targets of its actions during gestation. Lep and LepR are
differentially expressed in these tissues over the course
of pregnancy, and their presence in various cells types
indicates multiple paracrine/autocrine functions. Lep and
LepR are expressed both in the fetal and maternal sides of
the placenta; thus, a role in placental physiology and feto-
maternal cross-talk seems likely. The Lep signaling system
may be one of the pathways involved in the establishment
and maintenance of pregnancy, and may also play a regu-
latory role in parturition in the bitch.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
OB designed the study, carried out PCR, ISH and part of the IHC, analyzed
and interpreted the data, and wrote the manuscript. LPS performed the IHC,
contributed to data analysis and interpretation, and revised the manuscript.
AG helped with ISH, contributed to data interpretation and revised the
manuscript. AB contributed to critical discussions on the data and
interpretation, and revised the manuscript. MPK contributed to study design,
advised on laboratory procedures and data interpretation, and revised the
manuscript. IMR contributed to study design, advised on data evaluation and
interpretation, revised and edited the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
The authors thank Elisabeth Högger and Urs Büchler for their technical help.
We are grateful to Dr. Monika Hilbe and Dr. Elisabeth Eppler for advice and
discussions on immunohistochemistry.
Author details
1Clinic of Reproductive Medicine, Vetsuisse-Faculty, University of Zurich,
Winterthurerstrasse 260, 8057 Zurich, Switzerland. 2Institute of Veterinary
Anatomy, Vetsuisse-Faculty, University of Zurich, Winterthurerstrasse 260,
8057 Zurich, Switzerland.
Balogh et al. Reproductive Biology and Endocrinology  (2015) 13:13 Page 10 of 12
Received: 6 October 2014 Accepted: 6 February 2015
References
1. Kielar D, Clark JS, Ciechanowicz A, Kurzawski G, Sulikowski T, Naruszewicz M.
Leptin receptor isoforms expressed in human adipose tissue. Metabolism.
1998;47:844–7.
2. Jin L, Burguera BG, Couce ME, Scheithauer BW, Lamsan J, Eberhardt NL,
et al. Leptin and leptin receptor expression in normal and neoplastic
human pituitary: evidence of a regulatory role for leptin on pituitary cell
proliferation. J Clin Endocrinol Metab. 1999;84:2903–11.
3. González RR, Caballero-Campo P, Jasper M, Mercader A, Devoto L, Pellicer A,
et al. Leptin and leptin receptor are expressed in the human endometrium
and endometrial leptin secretion is regulated by the human blastocyst.
J Clin Endocrinol Metab. 2000;85:4883–8.
4. Ryan NK, Woodhouse CM, Van der Hoek KH, Gilchrist RB, Armstrong DT,
Norman RJ. Expression of leptin and its receptor in the murine ovary:
possible role in the regulation of oocyte maturation. Biol Reprod.
2002;66:1548–54.
5. Cervero A, Horcajadas JA, Martín J, Pellicer A, Simón C. The leptin system
during human endometrial receptivity and preimplantation development.
J Clin Endocrinol Metab. 2004;8:2442–51.
6. Martos-Moreno GA, Chowen JA, Argente J. Metabolic signals in human
puberty: effects of over and undernutrition. Mol Cell Endocrinol.
2010;324:70–81.
7. Herrid M, Palanisamy SK, Ciller UA, Fan R, Moens P, Smart NA, et al. An
updated view of leptin on implantation and pregnancy: a review. Physiol
Res. 2014;63:543–57.
8. Hardie L, Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women:
a longitudinal study in the menstrual cycle and during pregnancy.
Clin Endocrinol (Oxf). 1997;47:101–6.
9. Gavrilova O, Barr V, Marcus-Samuels B, Reitman M. Hyperleptinemia of
pregnancy associated with the appearance of a circulating form of the
leptin receptor. J Biol Chem. 1997;272:30546–51.
10. Amico JA, Thomas A, Crowley RS, Burmeister LA. Concentrations of leptin in
the serum of pregnant, lactating, and cycling rats and of leptin messenger
ribonucleic acid in rat placental tissue. Life Sci. 1998;63:1387–95.
11. Berg EL, McNamara DL, Keisler DH. Endocrine profiles of periparturient
mares and their foals. J Anim Sci. 2007;85:1660–8.
12. Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences
of maternal obesity. Placenta. 2013;34:205–11.
13. Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Mercer JG. Leptin
and leptin receptor mRNA and protein expression in the murine fetus and
placenta. Proc Natl Acad Sci U S A. 1997;94:11073–8.
14. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, et al.
Nonadipose tissue production of leptin: leptin as a novel placenta-derived
hormone in humans. Nat Med. 1997;3:1029–33.
15. Jansson N, Greenwood SL, Johansson BR, Powell TL, Jansson T. Leptin
stimulates the activity of the system A amino acid transporter in human
placental villous fragments. J Clin Endocrinol Metab. 2003;88:1205–11.
16. Mousiolis AV, Kollia P, Skentou C, Messinis IE. Effects of leptin on the
expression of fatty acid-binding proteins in human placental cell cultures.
Mol Med Rep. 2012;5:497–502.
17. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y. Leptin induces
vascular permeability and synergistically stimulates angiogenesis with FGF-2
and VEGF. Proc Natl Acad Sci U S A. 2001;98:6390–5.
18. Anagnostoulis S, Karayiannakis AJ, Lambropoulou M, Efthimiadou A,
Polychronidis A, Simopoulos C. Human leptin induces angiogenesis in vivo.
Cytokine. 2008;42:353–7.
19. Leiser R, Kaufmann P. Placental structure: in a comparative aspect. Exp Clin
Endocrinol. 1994;102:122–34.
20. Staun-Ram E, Shalev E. Human trophoblast function during the implantation
process. Reprod Biol Endocrinol. 2005;3:56.
21. Staun-Ram E, Goldman S, Gabarin D, Shalev E. Expression and importance
of matrix metalloproteinase 2 and 9 (MMP-2 and −9) in human trophoblast
invasion. Reprod Biol Endocrinol. 2004;2:59.
22. Castelucci M, De Matteis R, Meisser A, Cancello R, Monsurrò V, Islami D, et al.
Leptin modulates extracellular matrix molecules and metalloproteinases:
possible implications for trophoblast invasion. Mol Hum Reprod.
2000;6:951–8.
23. Gonzalez RR, Devoto L, Campana A, Bischof P. Effects of leptin, interleukin-1α,
interleukin-6, and transforming growth factor-β on markers of trophoblast
invasive phenotype: integrins and metalloproteinases. Endocrine.
2001;15:157–64.
24. Schulz LC, Widmaier EP. The effect of leptin on mouse trophoblast cell
invasion. Biol Reprod. 2004;71:1963–7.
25. Gonzalez RR, Leavis P. Leptin upregulates beta3-integrin expression and
interleukin-1beta, upregulates leptin and leptin receptor expression in
human endometrial epithelial cell cultures. Endocrine. 2001;16:21–8.
26. Gonzalez RR, Rueda BR, Ramos MP, Littell RD, Glasser S, Leavis PC.
Leptin-induced increase in leukemia inhibitory factor and its receptor
by human endometrium is partially mediated by interleukin 1 receptor
signaling. Endocrinology. 2004;145:3850–7.
27. Kawamura K, Sato N, Fukuda J, Kodama H, Kumagai J, Tanikawa H, et al.
Leptin promotes the development of mouse preimplantation embryos
in vitro. Endocrinology. 2002;143:1922–31.
28. Herrid M, Nguyen VL, Hinch G, McFarlane JR. Leptin has concentration and
stage-dependent effects on embryonic development in vitro. Reproduction.
2006;132:247–56.
29. Lange Consiglio A, Dell’Aquila ME, Fiandanese N, Ambruosi B, Cho YS,
Bosi G, et al. Effects of leptin on in vitro maturation, fertilization and
embryonic cleavage after ICSI and early developmental expression of
leptin (Ob) and leptin receptor (ObR) proteins in the horse. Reprod Biol
Endocrinol. 2009;7:113.
30. Ramos MP, Rueda BR, Leavis PC, Gonzalez RR. Leptin serves as an upstream
activator of an obligatory signaling cascade in the embryo-implantation
process. Endocrinology. 2005;146:694–701.
31. Sokolowski JH. The effects of ovariectomy on pregnancy maintenance in
the bitch. Lab Anim Sci. 1971;21:696–9.
32. Concannon PW, Hansel W, Visek WJ. The ovarian cycle of the bitch: plasma
estrogen, LH and progesterone. Biol Reprod. 1975;13:112–21.
33. Hoffmann B, Höveler R, Nohr B, Hasan SH. Investigations on hormonal changes
around parturition in the dog and the occurrence of pregnancy-specific non
conjugated oestrogens. Exp Clin Endocrinol. 1994;102:185–9.
34. Steinetz BG, Goldsmith LT, Lust G. Plasma relaxin in pregnant and lactating
dogs. Biol Reprod. 1987;37:719–25.
35. Jöchle W. Prolactin in canine and feline reproduction. Reprod Domest
Anim. 1997;32:183–93.
36. Onclin K, Murphy B, Verstegen JP. Comparisons of estradiol, LH and FSH
patterns in pregnant and nonpregnant beagle bitches. Theriogenology.
2002;57:1957–72.
37. Schäfer-Somi S, Beceriklisoy HB, Budik S, Kanca H, Aksoy OA, Polat B, et al.
Expression of genes in the canine pre-implantation uterus and embryo:
implications for an active role of the embryo before and during invasion.
Reprod Domest Anim. 2008;43:656–63.
38. Schäfer-Somi S, Klein D, Beceriklisoy HB, Sabitzer S, Ay SS, Agaoglu AR, et al.
Uterine progesterone receptor and leukaemia inhibitory factor mRNA
expression in canine pregnancy. Reprod Domest Anim. 2009;44 Suppl
2:109–14.
39. Beceriklisoy HB, Schäfer-Somi S, Kücükaslan I, Agaoglu R, Gültiken N, Ay SS,
et al. Cytokines, growth factors and prostaglandin synthesis in the uterus of
pregnant and non-pregnant bitches: the features of placental sites. Reprod
Domest Anim. 2009;44 Suppl 2:115–9.
40. Kautz E, Gram A, Aslan S, Ay SS, Selçuk M, Kanca H, et al. Expression of
genes involved in the embryo-maternal interaction in the early-pregnant ca-
nine uterus. Reproduction. 2014;147:703–17.
41. Kowalewski MP, Beceriklisoy HB, Pfarrer C, Aslan S, Kindahl H, Kücükaslan I,
et al. Canine placenta: a source of prepartal prostaglandins during normal
and antiprogestin-induced parturition. Reproduction. 2010;139:655–64.
42. Kowalewski MP, Michel E, Gram A, Boos A, Guscetti F, Hoffmann B, et al.
Luteal and placental function in the bitch: spatio-temporal changes in
prolactin receptor (PRLr) expression at dioestrus, pregnancy and normal
and induced parturition. Reprod Biol Endocrinol. 2011;9:109.
43. Gram A, Büchler U, Boos A, Hoffmann B, Kowalewski MP. Biosynthesis
and degradation of canine placental prostaglandins: prepartum
changes in expression and function of prostaglandin F2α-synthase
(PGFS, AKR1C3) and 15-hydroxyprostaglandin dehydrogenase (HPGD).
Biol Reprod. 2013;89:2.
44. Jeusette IC, Detilleux J, Shibata H, Saito M, Honjoh T, Delobel A, et al.
Effects of chronic obesity and weight loss on plasma ghrelin and leptin
concentrations in dogs. Res Vet Sci. 2005;79:169–75.
Balogh et al. Reproductive Biology and Endocrinology  (2015) 13:13 Page 11 of 12
45. Nishii N, Takasu M, Ohba Y, Maeda S, Kitoh K, Ohtsuka Y, et al. Effects of
administration of glucocorticoids and feeding status on plasma leptin
concentrations in dogs. Am J Vet Res. 2006;67:266–70.
46. Ishioka K, Hosoya K, Kitagawa H, Shibata H, Honjoh T, Kimura K, et al. Plasma
leptin concentration in dogs: effects of body condition score, age, gender
and breeds. Res Vet Sci. 2007;82(1):11–5.
47. Saleri R, Tirelli M, Grasselli F, Dondi M, Arisi M. Sexual dimorphism in leptin
blood levels in the dog. Veterinaria. 2003;17:47–51.
48. Balogh O, Kowalewski MP, Reichler IM. Leptin and leptin receptor gene
expression in the canine corpus luteum during diestrus, pregnancy
and after aglepristone-induced luteolysis. Reprod Domest Anim.
2012;47 Suppl 6:40–2.
49. Sorace M, Tripodi L, Tripodi A, Groppetti D, Cremonesi F. Leptin:
pharmacological aspects in gynecology. Clin Exp Obstet Gynecol.
2006;33:113–6.
50. Bartel C, Tichy A, Walter I. Characterization of foamy epithelial surface cells
in the canine endometrium. Anat Histol Embryol. 2014;43:165–81.
51. Kowalewski MP, Beceriklisoy HB, Aslan S, Agaoglu AR, Hoffmann B. Time
related changes in luteal prostaglandin synthesis and steroidogenic capacity
during pregnancy, normal and antiprogestin induced luteolysis in the bitch.
Anim Reprod Sci. 2009;116:129–38.
52. Bouchard GF, Solorzano N, Concannon PW, Youngquist RS, Bierschwal CJ.
Determination of ovulation time in bitches based on teasing, vaginal
cytology, and elisa for progesterone. Theriogenology. 1991;35:603–11.
53. Link KRJ, Allio I, Rand JS, Eppler E. The effect of experimentally induced
chronic hyperglycaemia on serum and pancreatic insulin, pancreatic islet
IGF-I and plasma and urinary ketones in the domestic cat (Felis felis). Gen
Comp Endocrinol. 2013;188:269–81.
54. Kowalewski MP, Schuler G, Taubert A, Engel E, Hoffmann B. Expression of
cyclooxygenase 1 and 2 in the canine corpus luteum during diestrus.
Theriogenology. 2006;66:1423–30.
55. Kowalewski MP, Mason JI, Howie AF, Morley SD, Schuler G, Hoffmann B.
Characterization of the canine 3β-hydroxysteroid dehydrogenase and its
expression in the corpus luteum during diestrus. J Steroid Biochem Mol Biol.
2006;101:254–62.
56. Kowalewski MP, Meyer A, Hoffmann B, Aslan S, Boos A. Expression and
functional implications of peroxisome proliferator-activated receptor
gamma (PPARγ) in canine reproductive tissues during normal pregnancy
and parturition and at antiprogestin induced abortion. Theriogenology.
2011;75:877–86.
57. Kitawaki J, Koshiba H, Ishihara H, Kusuki I, Tsukamoto K, Honjo H. Expression
of leptin receptor in human endometrium and fluctuation during the
menstrual cycle. J Clin Endocrinol Metab. 2000;85:1946–50.
58. Bukowska D, Kempisty B, Jackowska M, Woźna M, Antosik P, Piotrowska H,
et al. Analysis of integrins and vascular endothelial growth factor isoforms
mRNA expression in the canine uterus during perimplantation period. Pol J
Vet Sci. 2011;14:253–8.
59. Reese J, Das SK, Paria BC, Lim H, Song H, Matsumoto H, et al. Global gene
expression analysis to identify molecular markers of uterine receptivity and
embryo implantation. J Biol Chem. 2001;276:44137–45.
60. Yoon SJ, Cha KY, Lee KA. Leptin receptors are down-regulated in uterine
implantation sites compared to interimplantation sites. Mol Cell Endocrinol.
2005;232:27–35.
61. Dos Santos E, Serazin V, Morvan C, Torre A, Wainer R, de Mazancourt P,
et al. Adiponectin and leptin systems in human endometrium during
window of implantation. Fertil Steril. 2012;97:771–8. e1.
62. Ashworth CJ, Hoggard N, Thomas L, Mercer JG, Wallace JM, Lea RG.
Placental leptin. Rev Reprod. 2000;5:18–24.
63. Challier J, Galtier M, Bintein T, Cortez A, Lepercq J, Hauguel-de Mouzon S.
Placental leptin receptor isoforms in normal and pathological pregnancies.
Placenta. 2003;24:92–9.
64. Toth B, Fischl A, Scholz C, Kuhn C, Friese K, Karamouti M, et al. Insulin and
leptin receptors as possible new candidates for endocrine control in normal
and disturbed human pregnancy. Mol Hum Reprod. 2009;15:231–9.
65. Smolinska N, Siawrys G, Kaminski T, Przala J. Leptin gene and protein
expression in the trophoblast and uterine tissues during early pregnancy
and the oestrous cycle of pigs. J Physiol Pharmacol. 2007;58:563–81.
66. Smolinska N, Kaminski T, Siawrys G, Przala J. Long form of leptin receptor
gene and protein expression in the porcine trophoblast and uterine tissues
during early pregnancy and the oestrous cycle. Anim Reprod Sci.
2009;113:125–36.
67. Dall’Aglio C, Polisca A, Boiti C, Ceccarelli P. Immunolocalization of leptin and
its receptor in the placenta of cats. Acta Histochem. 2012;114:719–22.
68. Magariños MP, Sánchez-Margalet V, Kotler M, Calvo JC, Varone CL. Leptin
promotes cell proliferation and survival of trophoblastic cells. Biol Reprod.
2007;76:203–10.
69. Pérez-Pérez A, Maymó J, Gambino Y, Dueñas JL, Goberna R, Varone C, et al.
Leptin stimulates protein synthesis-activating translation machinery in
human trophoblastic cells. Biol Reprod. 2009;81:826–32.
70. Madej T, Boguski MS, Bryant SH. Threading analysis suggests that the obese
gene product may be a helical cytokine. FEBS Lett. 1995;373:13–8.
71. Molvarec A, Szarka A, Walentin S, Bekő G, Karádi I, Prohászka Z, et al. Serum
leptin levels in relation to circulating cytokines, chemokines, adhesion
molecules and angiogenic factors in normal pregnancy and preeclampsia.
Reprod Biol Endocrinol. 2011;9:124.
72. Nuamah MA, Yura S, Sagawa N, Itoh H, Mise H, Korita D, et al. Significant
increase in maternal plasma leptin concentration in induced delivery:
a possible contribution of pro-inflammaotry cytokines to placental leptin
secretion. Endocr J. 2004;51:177–87.
73. Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate the
release of proinflammatory cytokines and prostaglandins from human
placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal
proliferator-activated receptor-gamma and extracellularly regulated kinase
1/2. Endocrinology. 2005;146:3334–42.
74. Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem J.
2006;393:7–20.
75. Schulz LC, Widmaier EP. Leptin receptors. In: Castracane VD, Henson MC,
editors. Leptin. New York: Springer Science + Business Media LLC; 2006. p. 11–31.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Balogh et al. Reproductive Biology and Endocrinology  (2015) 13:13 Page 12 of 12
